The North America Liquid Handling System Market has seen robust growth fueled by advancements in laboratory automation and biotechnological research. This market is characterized by increasing adoption of automated liquid handling instruments, integration with software solutions, and a growing focus on improving throughput in research settings. The market, valued at USD 965 million in 2025, is expected to reach USD 2,320 million by 2035, at a CAGR of 8.9% from 2024 to 2035.
The economic impact of tariffs on "North America Liquid Handling System Market".
Market Growth Drivers
Rising Investment in Pharmaceutical & Biotechnology Research: The escalating R&D investment from pharmaceutical and biotechnology companies in North America is driving the demand for advanced liquid handling systems. For instance, companies like Thermo Fisher Scientific and Beckman Coulter have experienced significant orders for semi-automated and automated liquid handling systems as drug development pipelines expand and the need for high-throughput screening grows. This investment is not only boosting product innovation but also expanding accessibility to advanced lab automation tools.
Surge in Clinical Diagnostics and Genomics Applications: The increasing prevalence of chronic and infectious diseases, along with the rise in genomics-based diagnostics, propels the demand for precise and reliable liquid handling solutions. Firms such as Hamilton Company and Agilent Technologies are providing specialized solutions tailored for next-generation sequencing (NGS) and diagnostic sample processing—areas seeing significant growth as healthcare providers and research institutions aim to improve diagnostic accuracy and workflow efficiency.
Market Trends
Integration of Artificial Intelligence and Smart Automation: Leading market players are incorporating artificial intelligence and machine learning technologies into liquid handling systems to enhance workflow efficiency, reduce human error, and enable predictive maintenance. Companies such as PerkinElmer have launched smart automation platforms that utilize AI to optimize liquid transfer parameters, contributing to improved reproducibility and laboratory productivity.
Growing Shift Towards Modular and Flexible Workstations: There is a significant movement towards modular liquid handling platforms that can be easily customized and upgraded according to changing research requirements. Firms like Tecan Group are introducing modular systems that allow laboratories to adapt to fluctuating demands in sample volume and assay complexity, supporting both small- and large-scale operations in pharmaceuticals, diagnostics, and academic research.
Market Opportunities
Expansion into Point-of-Care and Decentralized Testing: As the demand for rapid diagnostics increases across North America, companies like Eppendorf AG are tapping into the market for compact, user-friendly liquid handling systems suited for decentralized and point-of-care applications, especially in remote healthcare settings.
Strategic Collaborations with Academic Institutions: Partnerships between companies such as Gilson Inc. and leading North American research universities create opportunities to develop customized liquid handling solutions tailored for advanced research projects, expanding the companies' reach and accelerating innovation.
North America Liquid Handling System Market Revenue (USD Million), 2020-2035
The chart demonstrates sustained market growth in the North America Liquid Handling System Market, with revenue increasing from USD 564 million in 2020 to an estimated USD 965 million in 2025 and projected to reach USD 2,320 million by 2035. The growth trajectory reflects a strong compound annual growth rate (CAGR) of approximately 8.9% from 2024 to 2035. This revenue increase is primarily attributed to advancements in laboratory automation, the growing pharmaceutical and biotechnology sectors, and expanded clinical diagnostic applications. Year-on-year, the market experiences notable increments, signifying healthy adoption and investment across research, clinical, and industrial sectors in North America.
North America Liquid Handling System Market Share by Region (%) in 2025
The 2025 regional distribution pie chart indicates that the United States dominates the North America Liquid Handling System Market with a significant 68% share, attributed to substantial R&D investment, a large pharmaceutical base, and leading research institutions. Canada follows with 18%, benefiting from government funding in life sciences. Mexico holds a 9% share, driven by the growth of contract research and manufacturing services. Other regions in North America, comprising Caribbean markets and US territories, account for 3% and 2% respectively. This distribution underscores the United States' central position while highlighting rising opportunities for growth in Canada and Mexico as cross-border healthcare and research collaborations expand.
Recent Developments in North America Liquid Handling System Market
In April 2024, Hamilton Company announced the release of its next-generation Microlab VANTAGE liquid handling platform, featuring advanced AI-driven liquid dispensing algorithms for improved performance in genomics and clinical diagnostics workflows. This innovation is expected to enhance throughput and reproducibility for both high- and low-volume laboratories across North America.
In March 2024, Thermo Fisher Scientific partnered with a major Canadian research institute to develop a customized automated liquid handling system aimed at accelerating COVID-19 and influenza diagnostic testing. This collaboration involves substantial integration of robotics and advanced software, underscoring the trend towards tailored solutions for emerging healthcare needs.
In January 2024, Beckman Coulter Life Sciences introduced its Biomek NGeniuS liquid handling automation system to the U.S. and Canadian markets, specifically targeting applications in next-generation sequencing (NGS) sample preparation. This launch follows feedback from clinical genetics labs and offers streamlined, user-friendly automation that reduces hands-on time and error rates, supporting precision medicine initiatives.